中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer

文献类型:期刊论文

作者Sun, Fang1,2,3; Zhu, Qiurong2,3; Li, Tianliang2,3; Saeed, Madiha2,3; Xu, Zhiai4; Zhong, Feisheng2,3; Song, Rundi2,3; Huai, Manxiu1; Zheng, Mingyue2,3; Xie, Cen2,3
刊名ADVANCED SCIENCE
出版日期2021-01-04
页码12
关键词glucose metabolism immunogenic cell death pancreatic cancer photoimmunotherapy prodrug nanoparticles
DOI10.1002/advs.202002746
通讯作者Xu, Leiming(xuleiming@xinhuamed.com.cn) ; Yu, Haijun(hjyu@simm.ac.cn)
英文摘要The low immunogenicity, insufficient infiltration of T lymphocytes, and dismal response to immune checkpoint blockade therapy pose major difficulties in immunotherapy of pancreatic cancer. Photoimmunotherapy by photodynamic therapy (PDT) can induce an antitumor immune response by triggering immunogenic cell death in the tumor cells. Notwithstanding, PDT-driven oxygen consumption and microvascular damage can further aggravate hypoxia to exaggerates glycolysis, leading to lactate accumulation and immunosuppressive tumor microenvironment. Herein, a supramolecular prodrug nanoplatform codelivering a photosensitizer and a prodrug of bromodomain-containing protein 4 inhibitor (BRD4i) JQ1 for combinatory photoimmunotherapy of pancreatic cancer are demonstrated. The nanoparticles are fabricated by host-guest complexation between cyclodextrin-grafted hyaluronic acid (HA-CD) and adamantine-conjugated heterodimers of pyropheophorbide a (PPa) and JQ1, respectively. HA can achieve active tumor targeting by recognizing highly expressed CD44 on the surface of pancreatic tumors. PPa-mediated PDT can enhance the immunogenicity of the tumor cells and promote intratumoral infiltration of the cytotoxic T lymphocytes. Meanwhile, JQ1 combats PDT-mediated immune evasion through inhibiting expression of c-Myc and PD-L1, which are key regulators of tumor glycolysis and immune evasion. Collectively, this study presents a novel strategy to enhance photoimmunotherapy of the pancreatic cancer by provoking T cells activation and overcoming adaptive immune resistance.
WOS关键词GUIDED PHOTODYNAMIC THERAPY ; RESISTANCE ; MICROENVIRONMENT ; PEMBROLIZUMAB ; CHEMOTHERAPY ; INHIBITION ; RECURRENCE ; ANTIBODY
资助项目National Natural Science Foundation of China[51873228] ; National Natural Science Foundation of China[21675055] ; International Cooperation Project of Science and Technology Commission of Shanghai Municipality[20430711800] ; Natural Science Foundation of Shanghai[19140901602] ; Natural Science Foundation of Shandong Province[ZR2019LZL020] ; China Postdoctoral Science Foundation[2019M661667] ; Shanghai Post-Doctoral Excellence Program[2019116] ; Open Fund of the State Key Laboratory of Drug Research[SIMM2004KF-04]
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science
语种英语
WOS记录号WOS:000604282900001
出版者WILEY
源URL[http://119.78.100.183/handle/2S10ELR8/296294]  
专题新药研究国家重点实验室
通讯作者Xu, Leiming; Yu, Haijun
作者单位1.Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 2000092, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China
4.East China Normal Univ, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China
5.Yantai Inst Mat Med, Yantai Key Lab Nanomed & Adv Preparat, Yantai 264000, Shandong, Peoples R China
推荐引用方式
GB/T 7714
Sun, Fang,Zhu, Qiurong,Li, Tianliang,et al. Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer[J]. ADVANCED SCIENCE,2021:12.
APA Sun, Fang.,Zhu, Qiurong.,Li, Tianliang.,Saeed, Madiha.,Xu, Zhiai.,...&Yu, Haijun.(2021).Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer.ADVANCED SCIENCE,12.
MLA Sun, Fang,et al."Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer".ADVANCED SCIENCE (2021):12.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。